0001117480-17-000019.txt : 20170724 0001117480-17-000019.hdr.sgml : 20170724 20170721193019 ACCESSION NUMBER: 0001117480-17-000019 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170724 DATE AS OF CHANGE: 20170721 EFFECTIVENESS DATE: 20170724 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NanoCellect Biomedical, Inc. CENTRAL INDEX KEY: 0001658031 IRS NUMBER: 275410493 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-270052 FILM NUMBER: 17977384 BUSINESS ADDRESS: STREET 1: 6404 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 9519664963 MAIL ADDRESS: STREET 1: 7770 REGENTS ROAD, #113390 CITY: SAN DIEGO STATE: CA ZIP: 92122 D/A 1 primary_doc.xml X0708 D/A LIVE 0001658031 NanoCellect Biomedical, Inc. 6865 Flanders Drive, Suite A SAN DIEGO CA CALIFORNIA 92121 9519664963 DELAWARE None None Corporation true Jose Morachis 6865 Flanders Drive, Suite A SAN DIEGO CA CALIFORNIA 92121 Executive Officer Director William Alaynick 6865 Flanders Drive, Suite A SAN DIEGO CA CALIFORNIA 92121 Executive Officer Director Jack Ball 6865 Flanders Drive, Suite A SAN DIEGO CA CALIFORNIA 92121 Director Nate Heintzman 6865 Flanders Drive, Suite A SAN DIEGO CA CALIFORNIA 92121 Executive Officer Director Kenneth Hood 6865 Flanders Drive, Suite A SAN DIEGO CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b true 0001658031-16-000003 2016-08-26 false true true Consists of Convertible Promissory Note convertible into shares of Preferred Stock of the Issuer. false 0 3000000 2466500 533500 false 4 0 0 0 false NanoCellect Biomedical, Inc. /s/ Jose Morachis Jose Morachis President and CEO 2017-07-21